Torbay Pharmacy Manufacturing Unit appoints md
Dr Nick Frampton to run the unit
Frampton joins the firm from Advanced Medical Solutions Group, where he was vice president of sales and marketing and contributed to a period of double-digit growth. He has formerly held quality, technical and commercial roles at West Pharmaceutical Services, Ernest Jackson and Banner Pharmacaps.
You may also like
Finance
![Aplagon closes €4.8m round to advance first-in-class antithrombotic APAC into Phase II AVF trial]()
Aplagon closes €4.8m round to advance first-in-class antithrombotic APAC into Phase II AVF trial
The financing supports a European CTA filing with the EMA for arteriovenous fistula maturation failure in end-stage kidney disease, expanding APAC's clinical programme across thrombo-inflammatory indications
Manufacturing
![AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn]()
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn
AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Finance
![GSK acquires Nuvalent for $10.6bn to accelerate NSCLC pipeline with FDA-reviewed ROS1 and ALK inhibitors]()
GSK acquires Nuvalent for $10.6bn to accelerate NSCLC pipeline with FDA-reviewed ROS1 and ALK inhibitors
GSK has agreed to acquire clinical-stage oncology company Nuvalent for $10.6bn, securing two late-stage next-generation kinase inhibitors — zidesamtinib and neladalkib — currently under FDA review for potential 2026 approval in non-small cell lung cancer
